Megestrol Acetate Suspension
Product Images NDC 17856-0060

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Megestrol Acetate (NDC 17856-0060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (17856 0060 01)

Label for Megestrol Acetate oral suspension, 400 mg/10 mL strength. The label details dosage form as suspension, with a quantity of 72 cups. It includes storage instructions to keep the suspension between 20°C to 25°C and notes an alcohol content of 0.06%. The product is distributed by Atlantic Biologicals Corp and packaged by Unit Dose Solutions, Morrisville, NC.*

FDA Label Image

Image Description (17856 0060 02)

Label for Megestrol Acetate oral suspension, USP 800 mg per 20 mL, delivered as 20 mL. The label includes storage instructions to keep the suspension between 20° to 25°C (68° to 77°F), notes alcohol content of 0.06%, and warnings to keep out of reach of children. The product is distributed by Atlantic Biologicals Corp. and packaged by Unit Dose Solutions, Morrisville, NC. A barcode and QR code are also visible along with expiration and lot numbers.*

FDA Label Image

Chemical Formula (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 01)

Chemical structure of megestrol acetate, shown as a detailed molecular diagram with chemical bonds and groups labeled. The structure includes methyl groups, ketone, and acetate functional groups characteristic of megestrol acetate.*

FDA Label Image

Trial 1 (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 02)

A line graph labeled "TRIAL 1" showing mean weight change in pounds over a 12-week period. The x-axis represents weeks (0, 4, 8, 12) and the y-axis represents mean weight change from -3 to 12 pounds. Five lines represent different doses: 800 mg, 400 mg, 100 mg, placebo, with corresponding data points showing trends in weight change over time.*

FDA Label Image

Trial 2 (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 03)

A line graph titled 'TRIAL 2' showing mean weight change in pounds over 12 weeks. The x-axis represents weeks (0 to 12), and the y-axis represents mean weight change in pounds (-3 to 12). Two lines are plotted: one for 800 mg treatment showing an increasing weight trend, and one for placebo showing a decreasing or stable weight trend.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.